Status:
COMPLETED
Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Severe Alcoholic Hepatitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
After successful screening, first the investigators first treat patients of severe alcoholic hepatitis with steroids for 7 days. Patients who are found to be unresponsive as per Lille's score \[\>0.45...
Eligibility Criteria
Inclusion
- \- Severe alcoholic hepatitis patients \[Maddrey's score \> 32\] aged between 18 to 65 years.
Exclusion
- Presence of active infections
- Acute GI bleed
- Hepatorenal syndrome
- Patient unwilling
- DF\>120
- Autoimmune hepatitis
- Hepatitis B, Hepatitis C, HIV cases
- Pregnancy
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01820208
Start Date
March 1 2014
End Date
June 1 2017
Last Update
November 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India, 110070